1-6 of 6
indolent
Close
Sort by
Journal Articles

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Catherine S. Diefenbach, Brandilyn A. Peters, Huilin Li, Bruce Raphael, Tibor Moskovits, Kenneth Hymes, Jonas Schluter, J. Chen, N. Nora Bennani, Thomas E. Witzig, Jiyoung Ahn
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1194–1198.
https://doi.org/10.1182/bloodadvances.2020003129
Published: 2021
Includes: Supplemental data
Journal Articles

Phase 1/2a study of 177 Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Clinical Trials & Observations
Arne Kolstad, Tim Illidge, Nils Bolstad, Signe Spetalen, Ulf Madsbu, Caroline Stokke, Johan Blakkisrud, Ayca Løndalen, Noelle O'Rourke, Matthew Beasley, Wojciech Jurczak, Unn-Merete Fagerli, Michal Kaščák, Mike Bayne, Aleš Obr, Jostein Dahle, Lisa Rojkjaer, Veronique Pascal, Harald Holte
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4091–4101.
https://doi.org/10.1182/bloodadvances.2020002583
Published: 2020
Includes: Supplemental data
Journal Articles

Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia

Clinical Trials & Observations
Shady Adnan Awad, Matti Kankainen, Teija Ojala, Perttu Koskenvesa, Samuli Eldfors, Bishwa Ghimire, Ashwini Kumar, Soili Kytölä, Mahmoud M. Kamel, Caroline A. Heckman, Kimmo Porkka, Satu Mustjoki
Journal: Blood Advances
Blood Adv (2020) 4 (3): 546–559.
https://doi.org/10.1182/bloodadvances.2019000943
Published: 2020
Includes: Supplemental data
Journal Articles

Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models

Animesh Pardanani, Sahrish Shah, Francesco Mannelli, Yoseph C. Elala, Paola Guglielmelli, Terra L. Lasho, Mrinal M. Patnaik, Naseema Gangat, Rhett P. Ketterling, Kaaren K. Reichard, Curtis A. Hanson, Alessandro M. Vannucchi, Ayalew Tefferi
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2964–2972.
https://doi.org/10.1182/bloodadvances.2018026245
Published: 2018
Journal Articles

Impact of somatic and germline mutations on the outcome of systemic mastocytosis

Clinical Trials & Observations
Javier I. Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, Jason D. Merker, Cristina Teodosio, Yanli Hou, Ana Henriques, Krishna M. Roskin, Laura Sanchez-Muñoz, Albert G. Tsai, Carolina Caldas, Almudena Matito, J. Ignacio Sánchez-Gallego, Andrea Mayado, Noelia Dasilva-Freire, Jason R. Gotlib, Luis Escribano, Alberto Orfao, Andrés C. García-Montero
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2814–2828.
https://doi.org/10.1182/bloodadvances.2018020628
Published: 2018
Includes: Supplemental data
Journal Articles

Clonality of HTLV-1–infected T cells as a risk indicator for development and progression of adult T-cell leukemia

Sanaz Firouzi, Amir Farmanbar, Kenta Nakai, Masako Iwanaga, Kaoru Uchimaru, Atae Utsunomiya, Yutaka Suzuki, Toshiki Watanabe
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1195–1205.
https://doi.org/10.1182/bloodadvances.2017005900
Published: 2017
Includes: Supplemental data